Is there a role of magnetic resonance imaging in deciding to stop anti-tumor necrosis factor treatment in ileal Crohn's disease?

被引：5

作者：

Gallego, Jose C. ^{[1
]}

Echarri, Ana ^{[2
]}

机构：

[1] Complexo Hosp Univ Ferrol, Radiol Dept, Av Residencia S-N, Ferrol 15405, Spain

[2] Complexo Hosp Univ Ferrol, Gastroenterol Dept, Ferrol, Spain

来源：

CLINICAL IMAGING | 2017年 / 43卷

关键词：

Crohn's disease; Magnetic resonance imaging; Anti-tumor necrosis factor agents; INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB THERAPY; CLINICAL REMISSION; FOLLOW-UP; DISCONTINUATION; MAINTENANCE; RELAPSE;

D O I：

10.1016/j.clinimag.2017.03.010

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Purpose: This study was performed to assess the ability of magnetic resonance enterography to predict the evolution of patients in whom anti-tumor necrosis factor-alpha therapy was suspended. Methods: A prospective study of patients with ileal Crohn's disease was performed. Results: Twenty-nine patients were included. Patients who later relapsed showed higher magnetic resonance scores than those who did not relapse (4.2 vs. 2.5, respectively; p < 0.02). The area under the receiving-operating characteristics curve was 0.755 when discriminating patients who relapsed. Conclusions: Magnetic resonance enterography should be taken into account when deciding the withdrawal of anti-tumor necrosis factor-alpha in patients with Crohn's disease. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：175 / 179

页数：5

共 20 条

[1] Normalized wall thickness at MRE predicts clinical remission in Crohn's disease after infliximab discontinuation: a 5 years follow-up [J].

Annunziata, M. L. ;

Papparella, L. G. ;

Sansoni, I. ;

Balestrieri, P. ;

Cicala, M. .

JOURNAL OF CROHNS & COLITIS, 2014, 8 :S233-S233

[2] Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease [J].

Deepak, Parakkal ;

Fletcher, Joel G. ;

Fidler, Jeff L. ;

Barlow, John M. ;

Sheedy, Shannon P. ;

Kolbe, Amy B. ;

Harmsen, William S. ;

Loftus, Edward V. ;

Hansel, Stephanie L. ;

Becker, Brenda D. ;

Bruining, David H. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (07) :997-1006

[3]

Echarri A, 2013, J CROHNS COLITI, V7, pS171

[4] Adverse Events of Tumor Necrosis Factor Inhibitors [J].

Fellermann, Klaus .

DIGESTIVE DISEASES, 2013, 31 (3-4) :374-378

[5] Advancing Magnetic Resonance Imaging in Crohn's Disease [J].

Fujii, Toshimitsu ;

Naganuma, Makoto ;

Kitazunne, Yoshio ;

Saito, Elko ;

Nagahori, Masakazu ;

Ohtsuka, Kazuo ;

Watanabe, Mamoru .

DIGESTION, 2014, 89 (01) :24-30

[6] Ileal Crohn's disease: MRI with endoscopic correlation [J].

Gallego, Jose C. ;

Echarri, Ana I. ;

Porta, Ana ;

Ollero, Virginia .

EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (02) :E8-E12

[7] Impact of disease location on fecal calprotectin levels in Crohn's disease [J].

Gecse, Krisztina B. ;

Brandse, Johannan F. ;

van Wilpe, Sandra ;

Lowenberg, Mark ;

Ponsioen, Cyriel ;

van den Brink, Gijs ;

D'Haens, Geert .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) :841-847

[8] Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy [J].

Gisbert, J. P. ;

Marin, A. C. ;

Chaparro, M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) :391-405

[9] Management of Crohn's Disease in Adults [J].

Lichtenstein, Gary R. ;

Hanauer, Stephen B. ;

Sandborn, William J. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02) :465-483

[10] Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease [J].

Louis, E ;

Collard, A ;

Oger, AF ;

Degroote, E ;

El Yafi, FAN ;

Belaiche, J .

GUT, 2001, 49 (06) :777-782

← 1 2 →